Le Lézard
Classified in: Health
Subjects: CCA, SLS

Capio to Publish Interim Report on July 20, 2018


GÖTHENBURG, June 29, 2018 /PRNewswire/ -- Capio AB will publish the Interim report for January-June 2018 on Friday, July 20 at approximately 08.00 am (CET).

08.00 am (approximately)

Report release. The report will be sent as a press release and will be published on Capio's website www.capio.com.

09.30 am Telephone conference and audio cast

Investors, analysts and media are invited to participate in a telephone conference at 09.30 am (CET).

President and CEO Thomas Berglund and CFO Olof Bengtsson will present the report and answer questions (in English).

The telephone conference will be audio casted live on www.capio.com.

To participate in the telephone conference, please register at www.capio.com and dial in five minutes prior to the start of the conference call.

Sweden: +46-8-566-426-93
UK: +44-20-3008-9804
US: +1-855-831-5944
Finland: +35-898-171-04-94
France: +33-170-75-07-12

Prior to the start of the telephone conference, presentation slides will be available at www.capio.com.

A recorded version of the audio cast will be made available at

www.capio.com

during the afternoon (CET).

Subscribe to press releases and financial information

To receive press releases and financial reports from Capio, please subscribe at www.capio.com/subscribe.

For information, please contact:
Olof Bengtsson
CFO
Telephone: +46-761-18-74-69

Kristina Ekeblad
IR manager
Telephone: +46-708-31-19-40

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/capio-ab/r/capio-to-publish-interim-report-on-july-20--2018,c2560728

The following files are available for download:

http://mb.cision.com/Main/277/2560728/868767.pdf

PDF


These press releases may also interest you

at 06:05
Global nonprofit BrightFocus Foundation announces $10 million in new Alzheimer's disease, macular degeneration, and glaucoma research grant funding?age-related diseases with no cure that affect more than 335 million people worldwide. This year's...

at 06:00
Proposed Divestment of Branded Prescription Pharma Business Further Supports Perrigo's Strategic Focus on Consumer Self-Care Total Purchase Consideration of up to ?275 Million, Consisting of ?190 Million in Cash Upfront and up to ?85 Million in...

at 06:00
Dr. Luz Hernandez, a leading dentist in Tampa, Florida has redefined her practice to focus on facial aesthetics. Facial Aesthetics by Dr. Luz, https://www.drluzh.com/, provides a wide...

at 06:00
West Pharmaceutical Services, Inc. today announced its financial results for the first-quarter 2024 and updated full-year 2024 financial guidance....

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...



News published on and distributed by: